jckrdu,
Ok, Nodded off a bit but got through entire CC. Well, you heard correctly as to what Rabin said... Even if you forget Socius numbers and look at numbers below you would have to buy the fact that 183MM options and warrants went off in the past 2 months. I for one don't buy it. If that happened for example and ALL warrants were exercised, wouldn't you think Rabin would mention the xtra $15MM+ in ACT's treasury? The S-1 info below describes the kind of cash we would have if all were exercised. I realize it was not 192MM as some were cancelled along the way but approx. 140-150MM were still there. So not one outstanding stock option or one outstanding warrant exist? So Lanza's options are all exercised too?(2)Includes 9,616,667 shares subject to stock options that are currently exercisable or exercisable within 60 days of February 7, 2011. And Rabin has no shares backing up his options either? Wonderful I say...:)
(warrant S-1)
This prospectus relates to the public offering of up to 192,148,119 shares of common stock, par value $.001 per share, of Advanced Cell Technology, Inc. (“Common Stock”), by the selling stockholders. These shares are issuable to the selling stockholders upon exercise of warrants which were issued to the selling stockholders in private placements in September 2005, August 2006, August 2007, and March 2008, and were amended and restated on July 29, 2009 (as amended and restated, the “Amended and Restated Warrants”). The Amended and Restated Warrants have an exercise price of $0.10 and a termination date of June 30, 2014.
(warrant S-1)
This prospectus relates to shares of our Common Stock that may be offered and sold from time to time by the selling stockholders. We will not receive any of the proceeds resulting from the sale of Common Stock by the selling stockholders. We will receive the sale price of any Common Stock we sell to the selling stockholders upon exercise of warrants for cash. If all of the warrants the underlying are shares of which are included in this prospectus are exercised for cash, we will receive $19,214,811.90. There is no assurance that any of the warrants will be exercised. We expect to use the proceeds received from the exercise of the warrants, if any, for general working capital purposes.
